A biotech with connections to Roche’s Genentech has now landed its newest cash infusion.
Microbiome outfit Novome Biotechnologies said Tuesday that it has now secured $43.5 million in new financing via a Series B round. The funds, according to the company, will be used to advance its lead candidate through…
